FDA approved two emergency INDs for COVID-19 outpatient therapy
On Aug. 6, 2020, Organicell Regenerative Medicine, a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies,…
-
-
NIH began clinical trial testing remdesivir plus interferon beta-1a for COVID-19 treatment
On Aug. 5, 2020, a randomized, controlled clinical trial evaluating the safety and efficacy of a treatment regimen…
-
NIH launched clinical trial to test antibody treatment in hospitalized COVID-19 patients
On Aug. 4, 2020, the National Institutes of Health (NIH) announced that patients admitted with COVID-19 at select…
-
Biotechnology | CDC | Diagnostics | Disease | Neurology | Therapeutics
CDC announced that 2020 outbreak of life-threatening acute flaccid myelitis expected
On Aug. 4, 2020, The Centers for Disease Control and Prevention (CDC) anticipates that 2020 will be another…
-
Mateon and Abiogenesis to initiate clinical study to test Artemisinin as a treatment for COVID-19 in India
On Aug. 4, 2020, Mateon Therapeutics and Abiogenesis announced they will be working together with Abiogenesis to initiate…
-
Innovation Pharma and US Regional Biocontainment Laboratory updated brilacidin anti-SARS-CoV-2 in vitro testing
On Aug. 4, 2020, Innovation Pharma reported receiving an update from a U.S. Regional Biocontainment Laboratory (RBL) based…
-
Cocrystal Pharma announced publication of positive data demonstrating potent in vitro inhibition against Coronavirus
On Aug. 4, 2020, Cocrystal Pharma announced the publication of preclinical animal studies of coronavirus antiviral compounds in…
-
Oxford University and ZOE partnered on COVID-19 treatment trials
On Aug. 3, 2020, the University of Oxford and the COVID Symptom Study joined forces to widen access…
-
Members of the COVID R&D alliance and quantum leap healthcare collaborative enrolled first patients in I-SPY COVID trial
On Aug. 3, 2020, members of the COVID R&D Alliance AbbVie, Amgen and Takeda Pharma announced the first…
-
Atossa Therapeutics received approval to open clinical study of AT-301 nasal spray being developed to treat COVID-19
On Aug. 3, 2020, Atossa Therapeutics announced that it had received approval from the ethics committee to open…
-
Researchers reported fat-based molecules key to Zika virus infection
On Jul. 31, 2020, researchers from the Pacific Northwest National Laboratory (PNNL) and Oregon Health & Science University…
-
NIH researchers discovered new set of channels connecting malaria parasite and blood cells
On Jul. 30, 2020, researchers at the National Institutes of Health and other institutions announced they had discovered…
-
RedHill Biopharma initiated global phase 2/3 study for COVID-19
On Jul. 30, 2020, RedHill Biopharma announced that it has initiated a global Phase 2/3 clinical study evaluating…
-
Biotechnology | COVID-19 | Diagnostics | FDA | Therapeutics
LabCorp announced work wth public health authorities on no-charge antibody test program to accelerate COVID-19 blood plasma donation
On Jul. 30, 2020, LabCorp launched the LabCorp At Home COVID-19 Test Collection Service, the first seamless digital…
-
Biotechnology | Diagnostics | Disease | Genomics | NIH | Therapeutics
NIH-funded project created an encyclopedia detailing the inner workings of the human and mouse genomes
On Jul. 29, 2020, the Encyclopedia of DNA Elements (ENCODE) Project is a worldwide effort to understand how…
-
Constant Therapeutics announced start of phase 2 trial of peptide drug TXA127 for COVID-19
On Jul. 29, 2020, Constant Therapeutics announced that its peptide drug TXA127, a pharmaceutical formulation of the natural…
-
BARDA procured Regeneron’s REGN-EB3 investigational Ebola treatment for national preparedness
On Jul. 29, 2020, Regeneron announced that the Biomedical Advanced Research and Development Authority (BARDA) had entered into…
-
Soligenix announced publication of positive pre-clinical results for a novel COVID-19 vaccine
On Jul. 28, 2020, Soligenix announced publication of pre-clinical immunogenicity studies for its CiVax™ program (heat stable COVID-19…
-
Apogenix started European clinical phase II trial with Asunercept in COVID-19 patients
On Jul. 28, 2020, Apogenix announced that it had received regulatory approval to start a clinical phase II…
-
Gilead Sciences and Satcher Health Leadership Institute partnered to study racial health inequities associated with COVID-19
On Jul. 28, 2020, Gilead Sciences and the Satcher Health Leadership Institute at Morehouse School of Medicine announced…
-
StartX Med Alliance of Remote and Telehealth companies respond to shift in patient care during COVID-19 crisis
On Jul. 28, 2020, StartX announced the launch of its StartX Med Alliance of Remote and Telehealth (SMART)…
-
NIH invested $58 million to catalyze data science and health research innovation in Africa
On Jul. 27, 2020, the National Institutes of Health (NIH) launched a $58 million initiative to advance data…
-
Immunic announced first patients enrolled in investigator-sponsored phase 2 clinical trial of IMU-838 in combination with Oseltamivir for treatment of patients with COVID-19
On Jul. 27, 2020, Immunic announced enrollment of the first patients in an investigator-sponsored phase 2 clinical trial…
-
NIH awarded $9.5 million for Einstein-Mount Sinai Diabetes Research Center
On Jul. 27, 2020, Albert Einstein College of Medicine announced that it had received a $9.5 million, five-year…
-
Onconova Therapeutics submitted application for rigosertib to participate in federally funded human studies in COVID-19 disease
On Jul. 27, 2020, Onconova Therapeutics announced that it had submitted an application with the National Institute of…
-
Immune system variation can predict severe COVID-19 outcomes
On Jul. 27, 2020, Yale university researchers reported that differing immune system responses of patients with COVID-19 can…
-
Biotechnology | Clinical Research | COVID-19 | Diagnostics | Infectious Disease | Non-Profit Research | Therapeutics | Vaccine
CIRM board approved two new discovery research projects for COVID-19
On Jul. 24, 2020, the governing Board of the California Institute for Regenerative Medicine (CIRM) approved two new…
-
CDC released new resources and tools to support opening schools
On Jul. 23, 2020, the Centers for Disease Control and Prevention (CDC) released new science-based resources and tools…
-
AXIM Biotechnologies released Rapid NeuCovix test results showing strong agreement with COVID-19-based neutralization tests
On Jul. 23, 2020, AXIM Biotechnologies announced the completion of a study highlighting the performance of NeuCovix™, AXIM’s…
-
Evotec Biologics awarded $18.2 million DoD contract to produce monoclonal antibody products against COVID-19
On Jul. 22, 20120, Evotec announced that the U.S. Department of Defense (DoD) had awarded its Seattle-based subsidiary,…
